Lori Steelman

Lori Steelman currently serves as the Global Head of Clinical Scientists for Late Stage Life Cycle Management in Oncology Therapeutic Area at Servier Pharmaceuticals since April 2021. Prior to this role, Lori held various positions at Agios Pharmaceuticals, culminating in the role of Senior Director of Clinical Sciences, where responsibilities included the acquisition of the oncology business portfolio by Servier. With experience spanning over two decades in the pharmaceutical industry, Lori's background includes significant roles at Infinity Pharmaceuticals, AVEO Pharmaceuticals, Novartis, ARIAD Pharmaceuticals, and Antigenics, specializing in clinical sciences, biomarker analysis, and oncology clinical trials. Education includes a Master of Science in Genetics from Jefferson Health and a Bachelor of Science in Biotechnology from the University of Delaware.